Integral Health Asset Management’s BioNTech BNTX Stock Holding History

Integral Health Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.65M	Buy	+50,000	New	+$4.71M	0.18%	77
2025 Q2	–	Sell	-40,000	Closed	-$3.64M	–	79
2025 Q1	$3.64M	Sell	40,000 -60,000	-60%	-$6.72M	0.39%	62
2024 Q4	$11.4M	Buy	100,000 +50,000	+100%	+$5.71M	0.97%	36
2024 Q3	$5.94M	Buy	+50,000	New	+$4.6M	0.67%	40
2023 Q3	–	Sell	-36,000	Closed	-$3.89M	–	71
2023 Q2	$3.89M	Buy	+36,000	New	+$4.05M	0.48%	61
2021 Q3	–	Sell	-17,000	Closed	-$3.81M	–	79
2021 Q2	$3.81M	Buy	+17,000	New	+$3.21M	1.05%	38

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Integral Health Asset Management's BNTX Position: Q2 2026 in Review

Integral Health Asset Management opened a new position in BioNTech (BNTX) in Q2 2026: 50,000 shares worth $4.65M. The stake represents 0.18% of the portfolio and ranks #77 among its holdings. This is a return to the name: Integral Health Asset Management previously reported a position in BNTX as recently as Q1 2025.

Integral Health Asset Management first reported a position in BNTX in Q2 2021 and has held it in 6 quarters since. The position peaked at $11.4M in Q4 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Integral Health Asset Management held 50,000 shares of BioNTech worth $4.65M as of Q2 2026.
BioNTech was a new Integral Health Asset Management position in Q2 2026.
BioNTech made up 0.18% of Integral Health Asset Management's portfolio in Q2 2026, its #77 holding.
Integral Health Asset Management first reported a position in BioNTech in Q2 2021 and has held it in 6 quarters since.
Integral Health Asset Management's BioNTech position peaked at $11.4M in Q4 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.